US Pharm. 2009;34(3):36.
Adding to the breadth and depth of its existing product line, Dr. Reddy's Laboratories has launched five new generics into the U.S. market. These include levetiracetam tablets (250 mg, 500 mg, 750 mg, and 1,000 mg), the generic version of UCB's Keppra tablets; omeprazole capsules (40 mg), the generic version of AstraZeneca's Prilosec; lamotrigine CD chewable tablets (5 mg and 25 mg), the generic version of GlaxoSmithKline's Lamictal CD tablets; divalproex capsules and delayed- release pellets (125 mg), the generic version of Abbott's Depakote delayed-release capsules 125 mg; and lamotrigine tablets (25 mg, 100 mg, 150 mg, and 200 mg), the generic version of GlaxoSmithKline's Lamictal tablets.
